APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemostatic Gel

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

Selected research

Market Structure

Global Hemostatic Gel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025184 pages

Choose your research edition.

Industry ResearchHemostatic Gel Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostatic Gel Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Hemostatic Gel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostatic Gel Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostatic Gel Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.

North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.

Read the full market overview

In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.

This report provides an overview of the global Hemostatic Gel market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemostatic Gel and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemostatic Gel sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemostatic Gel market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemostatic Gel Segment by Company

Baxter

J&J

CryoLife

Integra Life Sciences

Advance Medical Solution

BD

CSL Behring

Pfizer

B Braun

Hemostatic Gel Segment by Type

Fibrin

Gelatin

Other

Hemostatic Gel Segment by Application

Minimally Invasive Surgery

General Surgery

Others

Hemostatic Gel Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Gel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Gel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Gel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemostatic Gel market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemostatic Gel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hemostatic Gel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hemostatic Gel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hemostatic Gel Industry Trends Table 2. Hemostatic Gel Industry Drivers Table 3. Hemostatic Gel Industry Opportunities and Challenges Table 4. Hemostatic Gel Industry Restraints Table 5. Global Hemostatic Gel Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hemostatic Gel Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hemostatic Gel Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Hemostatic Gel Sales Market Share by Manufacturers Table 9. Global Hemostatic Gel Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Hemostatic Gel Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hemostatic Gel Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hemostatic Gel Manufacturers, Product Type & Application Table 13. Global Hemostatic Gel Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemostatic Gel by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Fibrin Table 17. Major Manufacturers of Gelatin Table 18. Major Manufacturers of Other Table 19. Global Hemostatic Gel Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Hemostatic Gel Sales by Type (2021-2026) & (K Units) Table 21. Global Hemostatic Gel Sales by Type (2027-2032) & (K Units) Table 22. Global Hemostatic Gel Sales Market Share by Type (2021-2026) Table 23. Global Hemostatic Gel Sales Market Share by Type (2027-2032) Table 24. Global Hemostatic Gel Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Hemostatic Gel Revenue by Type (2021-2026) & (K Units) Table 26. Global Hemostatic Gel Revenue by Type (2027-2032) & (K Units) Table 27. Global Hemostatic Gel Revenue Market Share by Type (2021-2026) Table 28. Global Hemostatic Gel Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Minimally Invasive Surgery Table 30. Major Manufacturers of General Surgery Table 31. Major Manufacturers of Others Table 32. Global Hemostatic Gel Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Hemostatic Gel Sales by Application (2021-2026) & (K Units) Table 34. Global Hemostatic Gel Sales by Application (2027-2032) & (K Units) Table 35. Global Hemostatic Gel Sales Market Share by Application (2021-2026) Table 36. Global Hemostatic Gel Sales Market Share by Application (2027-2032) Table 37. Global Hemostatic Gel Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Hemostatic Gel Revenue by Application (2021-2026) & (K Units) Table 39. Global Hemostatic Gel Revenue by Application (2027-2032) & (K Units) Table 40. Global Hemostatic Gel Revenue Market Share by Application (2021-2026) Table 41. Global Hemostatic Gel Revenue Market Share by Application (2027-2032) Table 42. Global Hemostatic Gel Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Hemostatic Gel Sales by Region (2021-2026) & (K Units) Table 44. Global Hemostatic Gel Sales Market Share by Region (2021-2026) Table 45. Global Hemostatic Gel Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Hemostatic Gel Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Hemostatic Gel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 49. North America Hemostatic Gel Sales by Country (2027-2032) & (K Units) Table 50. Europe Hemostatic Gel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 52. Europe Hemostatic Gel Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Hemostatic Gel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Hemostatic Gel Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Hemostatic Gel Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Hemostatic Gel Sales by Country (2027-2032) & (K Units) Table 59. Global Hemostatic Gel Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Hemostatic Gel Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Hemostatic Gel Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Hemostatic Gel Revenue Market Share by Region (2021-2026) Table 63. Global Hemostatic Gel Revenue Market Share by Region (2027-2032) Table 64. Baxter Company Information Table 65. Baxter Business Overview Table 66. Baxter Hemostatic Gel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Baxter Hemostatic Gel Product Portfolio Table 68. Baxter Recent Development Table 69. J&J Company Information Table 70. J&J Business Overview Table 71. J&J Hemostatic Gel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. J&J Hemostatic Gel Product Portfolio Table 73. J&J Recent Development Table 74. CryoLife Company Information Table 75. CryoLife Business Overview Table 76. CryoLife Hemostatic Gel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. CryoLife Hemostatic Gel Product Portfolio Table 78. CryoLife Recent Development Table 79. Integra Life Sciences Company Information Table 80. Integra Life Sciences Business Overview Table 81. Integra Life Sciences Hemostatic Gel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Integra Life Sciences Hemostatic Gel Product Portfolio Table 83. Integra Life Sciences Recent Development Table 84. Advance Medical Solution Company Information Table 85. Advance Medical Solution Business Overview Table 86. Advance Medical Solution Hemostatic Gel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Advance Medical Solution Hemostatic Gel Product Portfolio Table 88. Advance Medical Solution Recent Development Table 89. BD Company Information Table 90. BD Business Overview Table 91. BD Hemostatic Gel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. BD Hemostatic Gel Product Portfolio Table 93. BD Recent Development Table 94. CSL Behring Company Information Table 95. CSL Behring Business Overview Table 96. CSL Behring Hemostatic Gel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. CSL Behring Hemostatic Gel Product Portfolio Table 98. CSL Behring Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Hemostatic Gel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Pfizer Hemostatic Gel Product Portfolio Table 103. Pfizer Recent Development Table 104. B Braun Company Information Table 105. B Braun Business Overview Table 106. B Braun Hemostatic Gel Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. B Braun Hemostatic Gel Product Portfolio Table 108. B Braun Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Hemostatic Gel Distributors List Table 112. Hemostatic Gel Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Hemostatic Gel Product Image Figure 2. Global Hemostatic Gel Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostatic Gel Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemostatic Gel Sales (2021-2032) & (K Units) Figure 5. Global Hemostatic Gel Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hemostatic Gel Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Fibrin Image Figure 9. Gelatin Image Figure 10. Other Image Figure 11. Global Hemostatic Gel Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Hemostatic Gel Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Hemostatic Gel Sales Market Share by Type (2021-2032) Figure 14. Global Hemostatic Gel Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Hemostatic Gel Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Hemostatic Gel Revenue Market Share by Type (2021-2032) Figure 17. Minimally Invasive Surgery Image Figure 18. General Surgery Image Figure 19. Others Image Figure 20. Global Hemostatic Gel Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Hemostatic Gel Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Hemostatic Gel Sales Market Share by Application (2021-2032) Figure 23. Global Hemostatic Gel Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Hemostatic Gel Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Hemostatic Gel Revenue Market Share by Application (2021-2032) Figure 26. North America Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Hemostatic Gel Sales Market Share by Country (2021-2032) Figure 28. U.S. Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Hemostatic Gel Sales Market Share by Country (2021-2032) Figure 33. Germany Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Hemostatic Gel Sales Market Share by Country (2021-2032) Figure 40. China Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Hemostatic Gel Sales Market Share by Country (2021-2032) Figure 48. Brazil Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Hemostatic Gel Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Hemostatic Gel Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Hemostatic Gel Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Hemostatic Gel Revenue (2021-2032) & (US$ Million) Figure 59. North America Hemostatic Gel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Hemostatic Gel Revenue (2021-2032) & (US$ Million) Figure 61. Europe Hemostatic Gel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Hemostatic Gel Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Hemostatic Gel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Hemostatic Gel Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Hemostatic Gel Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Hemostatic Gel Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Hemostatic Gel Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Fibrin
  • Gelatin
  • Other
Applications
  • Minimally Invasive Surgery
  • General Surgery
  • Others
Companies covered
  • Baxter
  • J&J
  • CryoLife
  • Integra Life Sciences
  • Advance Medical Solution
  • BD
  • CSL Behring
  • Pfizer
  • B Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hemostatic Gel Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hemostatic Gel Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hemostatic Gel Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hemostatic Gel Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hemostatic Gel Market Dynamics
  1. 2.1 Hemostatic Gel Industry Trends
  2. 2.2 Hemostatic Gel Industry Drivers
  3. 2.3 Hemostatic Gel Industry Opportunities and Challenges
  4. 2.4 Hemostatic Gel Industry Restraints
3 Hemostatic Gel Market by Manufacturers
  1. 3.1 Global Hemostatic Gel Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hemostatic Gel Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hemostatic Gel Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hemostatic Gel Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemostatic Gel Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hemostatic Gel Manufacturers, Product Type & Application
  7. 3.7 Global Hemostatic Gel Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemostatic Gel Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemostatic Gel Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemostatic Gel Tier 1, Tier 2, and Tier 3
4 Hemostatic Gel Market by Type
  1. 4.1 Hemostatic Gel Type Introduction
  2. 4.1.1 Fibrin
  3. 4.1.2 Gelatin
  4. 4.1.3 Other
  5. 4.2 Global Hemostatic Gel Sales by Type
  6. 4.2.1 Global Hemostatic Gel Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hemostatic Gel Sales by Type (2021-2032)
  8. 4.2.3 Global Hemostatic Gel Sales Market Share by Type (2021-2032)
  9. 4.3 Global Hemostatic Gel Revenue by Type
  10. 4.3.1 Global Hemostatic Gel Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Hemostatic Gel Revenue by Type (2021-2032)
  12. 4.3.3 Global Hemostatic Gel Revenue Market Share by Type (2021-2032)
5 Hemostatic Gel Market by Application
  1. 5.1 Hemostatic Gel Application Introduction
  2. 5.1.1 Minimally Invasive Surgery
  3. 5.1.2 General Surgery
  4. 5.1.3 Others
  5. 5.2 Global Hemostatic Gel Sales by Application
  6. 5.2.1 Global Hemostatic Gel Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hemostatic Gel Sales by Application (2021-2032)
  8. 5.2.3 Global Hemostatic Gel Sales Market Share by Application (2021-2032)
  9. 5.3 Global Hemostatic Gel Revenue by Application
  10. 5.3.1 Global Hemostatic Gel Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hemostatic Gel Revenue by Application (2021-2032)
  12. 5.3.3 Global Hemostatic Gel Revenue Market Share by Application (2021-2032)
6 Global Hemostatic Gel Sales by Region
  1. 6.1 Global Hemostatic Gel Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemostatic Gel Sales by Region (2021-2032)
  3. 6.2.1 Global Hemostatic Gel Sales by Region (2021-2026)
  4. 6.2.2 Global Hemostatic Gel Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hemostatic Gel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hemostatic Gel Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hemostatic Gel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hemostatic Gel Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hemostatic Gel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hemostatic Gel Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hemostatic Gel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hemostatic Gel Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hemostatic Gel Revenue by Region
  1. 7.1 Global Hemostatic Gel Revenue by Region
  2. 7.1.1 Global Hemostatic Gel Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hemostatic Gel Revenue by Region (2021-2026)
  4. 7.1.3 Global Hemostatic Gel Revenue by Region (2027-2032)
  5. 7.1.4 Global Hemostatic Gel Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hemostatic Gel Revenue (2021-2032)
  8. 7.2.2 North America Hemostatic Gel Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hemostatic Gel Revenue (2021-2032)
  11. 7.3.2 Europe Hemostatic Gel Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hemostatic Gel Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hemostatic Gel Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hemostatic Gel Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hemostatic Gel Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Baxter
  2. 8.1.1 Baxter Company Information
  3. 8.1.2 Baxter Business Overview
  4. 8.1.3 Baxter Hemostatic Gel Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Baxter Hemostatic Gel Product Portfolio
  6. 8.1.5 Baxter Recent Developments
  7. 8.2 J&J
  8. 8.2.1 J&J Company Information
  9. 8.2.2 J&J Business Overview
  10. 8.2.3 J&J Hemostatic Gel Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 J&J Hemostatic Gel Product Portfolio
  12. 8.2.5 J&J Recent Developments
  13. 8.3 CryoLife
  14. 8.3.1 CryoLife Company Information
  15. 8.3.2 CryoLife Business Overview
  16. 8.3.3 CryoLife Hemostatic Gel Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CryoLife Hemostatic Gel Product Portfolio
  18. 8.3.5 CryoLife Recent Developments
  19. 8.4 Integra Life Sciences
  20. 8.4.1 Integra Life Sciences Company Information
  21. 8.4.2 Integra Life Sciences Business Overview
  22. 8.4.3 Integra Life Sciences Hemostatic Gel Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Integra Life Sciences Hemostatic Gel Product Portfolio
  24. 8.4.5 Integra Life Sciences Recent Developments
  25. 8.5 Advance Medical Solution
  26. 8.5.1 Advance Medical Solution Company Information
  27. 8.5.2 Advance Medical Solution Business Overview
  28. 8.5.3 Advance Medical Solution Hemostatic Gel Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Advance Medical Solution Hemostatic Gel Product Portfolio
  30. 8.5.5 Advance Medical Solution Recent Developments
  31. 8.6 BD
  32. 8.6.1 BD Company Information
  33. 8.6.2 BD Business Overview
  34. 8.6.3 BD Hemostatic Gel Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BD Hemostatic Gel Product Portfolio
  36. 8.6.5 BD Recent Developments
  37. 8.7 CSL Behring
  38. 8.7.1 CSL Behring Company Information
  39. 8.7.2 CSL Behring Business Overview
  40. 8.7.3 CSL Behring Hemostatic Gel Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CSL Behring Hemostatic Gel Product Portfolio
  42. 8.7.5 CSL Behring Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Hemostatic Gel Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Hemostatic Gel Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 B Braun
  50. 8.9.1 B Braun Company Information
  51. 8.9.2 B Braun Business Overview
  52. 8.9.3 B Braun Hemostatic Gel Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 B Braun Hemostatic Gel Product Portfolio
  54. 8.9.5 B Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemostatic Gel Value Chain Analysis
  2. 9.1.1 Hemostatic Gel Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemostatic Gel Production Mode & Process
  6. 9.2 Hemostatic Gel Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemostatic Gel Distributors
  9. 9.2.3 Hemostatic Gel Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst